Quick Answer
Phio Pharmaceuticals Corp. reported Cash And Cash Equivalents At Carrying Value of $21.03 million for the year ending 2025.
- Phio Pharmaceuticals Corp. showed an increase of +290.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Phio Pharmaceuticals Corp.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2011 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $304.0 thousand | Q2 2012: $7.52 million | Q3 2012: $6.28 million | Q1 2013: $19.64 million | Q2 2013: $8.59 million | Q3 2013: $6.85 million | Q1 2014: $9.01 million | Q2 2014: $11.91 million | Q3 2014: $5.13 million | Q1 2015: $6.58 million | Q2 2015: $5.99 million | Q3 2015: $4.04 million | Q1 2016: $4.19 million | Q2 2016: $3.83 million | Q3 2016: $2.38 million | Q1 2017: $10.21 million | Q2 2017: $7.70 million | Q3 2017: $5.42 million | Q4 2017: $3.58 million | Q1 2018: $2.61 million | Q2 2018: $5.32 million | Q3 2018: $3.24 million | Q2 2023: $11.31 million | Q3 2023: $8.41 million | Q1 2024: $6.48 million | Q2 2024: $4.70 million | Q3 2024: $5.39 million | Q1 2025: $13.28 million | Q2 2025: $10.78 million | Q3 2025: $10.71 million.
- Over the full 10 years of available data (2011 to 2025), Phio Pharmaceuticals Corp.'s Cash And Cash Equivalents At Carrying Value has grown by 4,081.1%.
- Historical annual values: Fiscal year 2025: $21.03 million | Fiscal year 2024: $5.38 million | Fiscal year 2023: $8.49 million | Fiscal year 2017: $3.58 million | Fiscal year 2016: $12.91 million | Fiscal year 2015: $5.12 million | Fiscal year 2014: $8.50 million | Fiscal year 2013: $11.39 million | Fiscal year 2012: $5.13 million | Fiscal year 2011: $503.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: